GlassScriptPhysician profile
Ignacio Acevedo Sierra
NPI 1407942212
$3,319.29
in general payments reported to CMS, 2019-2025
20 companies · $549 in 2025
The $549 reported for 2025 was more than what 85% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $202 · 2021: $339 · 2022: $626 · 2023: $475 · 2024: $496 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $904.97 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $479.02 | 2019-2024 | Eliquis, Reblozyl |
| Abbvie INC. | $459.03 | 2019-2025 | Skyrizi, Vraylar, Ubrelvy |
| Pbg Puerto Rico LLC | $374.03 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $176.30 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $126.55 | 2019-2025 | Capvaxive |
| Medtronic, INC. | $114.91 | 2024-2025 | Solitaire X, Interstim |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.53 | 2019-2023 | Lifevest |
| Allergan, INC. | $89.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.09 | 2025 | |
| Sanofi-Aventis U.S. LLC | $75.82 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $66.13 | 2022-2024 | |
| Chiesi USA, INC. | $59.78 | 2019-2024 | Cleviprex |
| Lilly USA, LLC | $57.86 | 2025 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.82 | 2019-2025 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $24.49 | 2019 | |
| Bayer Puerto Rico INC. | $23.41 | 2025 | Kerendia |
| Amgen INC. | $21.14 | 2021 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $19.05 | 2025 | Zepbound |
| Pfizer Pharmaceuticals LLC | $15.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignacio Acevedo Sierra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.